This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

Hypercell Technologies Form D (2026)

Hypercell Technologies reported $2,958,378 raised in an SEC Form D filed on 2026-10-14.

Company
Hypercell Technologies
Round type
Form D
Date
2026-10-14
Amount
$2.96M
Industry
Biotechnology
Location
New York

Summary

The SEC Form D for Hypercell Technologies, filed on 2026-10-14, reports $2,958,378 raised. It was listed in the Raise Track Update of 2026-10-15. Filing: https://www.sec.gov/Archives/edgar/data/1882357/000188235726000004/0001882357-26-000004-index.htm

This page is not indexed by search engines yet because the filing is its only source.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/1882357/000188235726000004/0001882357-26-000004-index.htm
    Type: sec filing. Accessed 2026-10-15.
    SEC Form D for Hypercell Technologies Inc. EDGAR filing date 2026-10-14. Signed 2026-10-14. First sale 2026-09-08. Total amount sold $2,958,378 of an offering amount of $4,423,378. 14 investors already invested. Issuer address city is Ithaca, New York. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published. The form gives a related person's name as Bruno Georges Jactel. The page uses Bruno Jactel. The EDGAR filing index lists a business address in Brookhaven, Georgia. The issuer address on primary_doc.xml is Ithaca, New York, which matches the Raise Track Update. The page uses New York.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-15/
    Type: other verified public source. Accessed 2026-10-15.
    Raise Track Update for 2026-10-15, Section 3 (SEC Form D filings). Lists Hypercell Technologies, state NEW YORK, industry Biotechnology, amount raised $2,958,378.